Cellaïon
Entity

  • Cellaïon

    Created in 2009
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    790 8,530

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    Rue Granbonpré 11, 1435 Mont-Saint-Guibert, Belgium

    Mont-Saint-Guibert

    Belgium

  • Employees

    Scale: 11-50

    Estimated: 26

  • Engaged corporates

    2
    1 1

  • Added in Motherbase

    4 years, 10 months ago
Description
  • Value proposition

    Cell Signaling Technology for Organ Repair and Regeneration

    Cell Signaling Technology for Organ Repair and Regeneration
    We care for liver
    Our advanced therapy aims to restore liver function thanks to immunomodulatory and regenerative properties of Hepastem

    Cell therapy, Acquired liver diseases, Liver diseases, liver based genetic diseases, NASH, ACLF, Antibodies, Clinical stage, Chronic liver disease, Fatty liver, Acute liver disease, Regenerative medicine, Biotech, and Biotechnology

Corporate interactions BETA
Corporate TypeTweets Articles
La Tribune
La Tribune
Media, Newspapers
La Tribune
Media, Newspapers 		Other

26 Feb 2019


SRIW
SRIW
Venture Capital and Private Equity Principals
SRIW
Venture Capital and Private Equity Principals 		Capitalistic
Partnership
Not event

18 Jan 2022


Similar entities
Last news
Show all articles
Social network dynamics